1.The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development.
Tae Jung JANG ; Jeong Bae PARK ; Jong Im LEE
Korean Journal of Pathology 2013;47(4):340-347
BACKGROUND: The aim of this study was to examine the expression of CD10 and CD15 in tumor cells, stromal cells and infiltrating inflammatory cells during colorectal carcinoma (CRC) development and to investigate their expression levels between the tumor center and invasive front and compare them to clinicopathological parameters in invasive CRC. METHODS: We performed immunohistochemical staining for CD10, CD15, and E-cadherin in 42 cases of CRC, 49 of tubular adenoma, 15 of hyperplastic polyp, and 17 of non-neoplastic colon. RESULTS: CD10 was expressed in tumor cells (tCD10), stromal cells (sCD10) and infiltrating inflammatory cells (iCD10), and CD15 was expressed in tumor cells (tCD15) and infiltrating inflammatory cells (iCD15). Their expressions were progressively increased during CRC development and the iCD10 expression level was significantly correlated with the iCD15 expression level in invasive CRC. Invasive front revealed a higher expression level of iCD10 and iCD15 than the tumor center. Moreover, the iCD15 expression level of invasive front was significantly correlated with the degree of tumor budding and tCD15 in whole tissue sections was closely associated with tumor depth. CONCLUSIONS: The present study suggests that the expression of CD10 and CD15 is associated with the development and progression of CRC.
Adenoma
;
Antigens, CD15
;
Cadherins
;
Colorectal Neoplasms
;
Neprilysin
;
Polyps
;
Stromal Cells
2.Stemness Signature of Equine Marrow-derived Mesenchymal Stem Cells.
Morteza ZAHEDI ; Abbas PARHAM ; Hesam DEHGHANI ; Hossein Kazemi MEHRJERDI
International Journal of Stem Cells 2017;10(1):93-102
BACKGROUND: Application of competent cells such as mesenchymal stem cells (MSCs) for treatment of musculoskeletal disorders in equine athletes is increasingly needed. Moreover, similarities of horse and human in size, load and types of joint injuries, make horse as a good model for MSCs therapy studies. This study was designed to isolate and characterize stemness signature of equine bone marrow-derived mesenchymal stem cells (BM-MSCs). METHODS: BM of three mares was aspirated and the mononuclear cells (MNCs) were isolated using density gradient. The primary MNCs were cultured and analyzed after tree passages (P3) for growth characteristics, differentiation potentials, and the expression of genes including CD29, CD34, CD44, CD90, CD105, MHC-I, MHC-II and pluripotency related genes (Nanog, Oct-4, Sox-2, SSEA-1, -3, -4) using RT-PCR or immunocytochemistry techniques. RESULTS: The isolated cells in P3 were adherent and fibroblast-like in shape with doubling times of 78.15 h. Their clonogenic capacity was 8.67±4% and they were able to differentiate to osteogenic, adipogenic and chondrogenic lineages. Cells showed expression of CD29, CD44, CD90, MHC-I and Sox-2 while no expression for CD34, MHC-II, CD105, and pluripotency stemness markers was detected. CONCLUSIONS: In conclusion, data showed that isolated cells have the basic and minimal criteria for MSCs, however, expressing only one pluripotency gene (sox-2).
Antigens, CD15
;
Athletes
;
Bone Marrow
;
Horses
;
Humans
;
Immunohistochemistry
;
Joints
;
Mesenchymal Stromal Cells*
;
Trees
3.Stage-specific embryonic antigen: determining expression in canine glioblastoma, melanoma, and mammary cancer cells.
Weiming LIN ; Jaime F MODIANO ; Daisuke ITO
Journal of Veterinary Science 2017;18(1):101-104
The expression of stage-specific embryonic antigens (SSEAs) was determined in several types of canine cancer cells. Flow cytometry showed SSEA-1 expression in glioblastoma, melanoma, and mammary cancer cells, although none expressed SSEA-3 or SSEA-4. Expression of SSEA-1 was not detected in lymphoma, osteosarcoma, or hemangiosarcoma cell lines. Relatively stable SSEA-1 expression was observed between 24 and 72 h of culture. After 8 days in culture, sorted SSEA-1⁻ and SSEA-1⁺ cells re-established SSEA-1 expression to levels comparable to those observed in unsorted cells. Our results document, for the first time, the expression of SSEA-1 in several canine cancer cell lines.
Antigens, CD15
;
Breast Neoplasms*
;
Cell Line
;
Flow Cytometry
;
Glioblastoma*
;
Hemangiosarcoma
;
Lymphoma
;
Melanoma*
;
Osteosarcoma
;
Stage-Specific Embryonic Antigens*
4.Immunocytology of the Lewis X Antigen in Patients with Bladder Tumor.
Ung Chul NAM ; Sun Ju LEE ; Sung Jig LIM ; Juhie LEE ; Jin Il KIM
Korean Journal of Urology 1999;40(3):327-331
PURPOSE: To improve low sensitivity of urinary cytology in diagnosis and surveillance of bladder cancer, we performed a study using the Lewis X immunocytology with the murine BG-7 monoclonal anti-Lewis X immunoglobulin M antibody while comparing it with conventional urinary cytology. MATERIALS AND METHODS: Barbotage bladder washings were performed in 36 patients who were diagnosed as having bladder tumor after cystoscopy. The specimens were divided into conventional urinary cytology and immunocytochemical examinations. The cytologic examination was done according to Papanicolau. Indirect immunoperoxidase staining of urine samples was done using the murine BG-7 monoclonal antibody against the Lewis X antigen. Biopsies were obtained in all cases via transurethral resection. The results were analysed according to the tumor stage and grade. RESULTS: Of the 36 patients, 33 patients were diagnosed with transitional cell carcinoma, 1 with inverted papilloma, and 2 with chronic inflammation. Immunocytology showed positive results in 25 of the 33 patients, corresponding to a sensitivity of 75.8% while conventional cytology showed a sensitivity of 45.5%. This discrepancy was vivid in the cases of low grade transitional cell carcinoma. The sensitivities of conventional cytology were 23% in grade I and 50% in grade II, while those of immunocytology were 50% in grade I and 100% in grade II. CONCLUSIONS: Our data show that Lewis X immunocytology using the murine BG-7 monoclonal anti-Lewis X antibody can improve the sensitivity of noninvasive detection of transitional cell carcinoma of the bladder, especially in low grade tumor.
Antigens, CD15*
;
Biopsy
;
Carcinoma, Transitional Cell
;
Cystoscopy
;
Diagnosis
;
Humans
;
Immunoglobulin M
;
Inflammation
;
Papilloma, Inverted
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
5.The Molecular Nature of Very Small Embryonic-Like Stem Cells in Adult Tissues.
Yonghwan KIM ; Jaeho JEONG ; Hyunsook KANG ; Jisun LIM ; Jinbeom HEO ; Janina RATAJCZAK ; Mariusz Z RATAJCZAK ; Dong Myung SHIN
International Journal of Stem Cells 2014;7(2):55-62
Pluripotent stem cells (PSCs) have been considered as the most important cells in regenerative medicine as they are able to differentiate into all types of cells in the human body. PSCs have been established from several sources of embryo tissue or by reprogramming of terminally differentiated adult tissue by transduction of so-called Yamanaka factors (Oct4, Sox2, Klf4, and cMyc). Interestingly, accumulating evidence has demonstrated the residence of PSCs in adult tissue and with the ability to differentiate into multiple types of tissue-committed stem cells (TCSCs). We also recently demonstrated that a population of pluripotent Oct4(+) SSEA-1(+)Sca-1(+)Lin-CD45(-) very small embryonic-like stem cells (VSELs) resides in the adult murine bone marrow (BM) and in other murine tissue. These very small (~3-6 microm) cells express pluripotent markers such as Oct4, Nanog, and SSEA-1. VSELs could be specified into several tissue-residing TCSCs in response to tissue/organ injury, and thus suggesting that these cells have a physiological role in the rejuvenation of a pool of TCSCs under steady-state conditions. In this review article, we discuss the molecular nature of the rare population of VSELs which have a crucial role in regulating the pluripotency, proliferation, differentiation, and aging of these cells.
Adult*
;
Aging
;
Antigens, CD15
;
Bone Marrow
;
DNA Methylation
;
Embryonic Structures
;
Genomic Imprinting
;
Human Body
;
Humans
;
Pluripotent Stem Cells
;
Regenerative Medicine
;
Rejuvenation
;
Stem Cells*
6.Parthenogenetic Mouse Embryonic Stem Cells have Similar Characteristics to In Vitro Fertilization mES Cells.
Se Pill PARK ; Eun Young KIM ; Keum Sil LEE ; Young Jae LEE ; Hyun Ah SHIN ; Hyun Jung MIN ; Hoon Taek LEE ; Kil Saeng CHUNG ; Jin Ho LIM
Korean Journal of Fertility and Sterility 2002;29(2):129-138
OBJECTIVE: This study was to compare the characteristics between parthenogenetic mES (P-mES) cells and in vitro fertilization mES cells. MATERIAL AND METHODS: Mouse oocytes were recovered from superovulated 4 wks hybrid F1 (C57BL/6xCBA/N) female mice. For parthenogenetic activation, oocytes were treated with 7% ethanol for 5 min and 5microgram/ml cytochalasin-B for 4 h. For IVF, oocytes were inseminated with epididymal perm of hybrid F1 male mice(1x106/ml). IVF and parthenogenetic embryos were cultured in M16 medium for 4 days. Cell number count of blastocysts in those two groups was taken by differential labelling using propidium iodide (red) and bisbenzimide (blue). To establish ES cells, blastocysts in IVF and parthenogenetic groups were treated by immunosurgery and recovered inner cell mass (ICM) cells were cultured in LIF added ES culture medium. To identity ES cells, the surface markers alkaline phosphatase, SSEA-1, 3, 4 and Oct4 staining were examined in replated ICM colonies. Chromosome numbers in P-mES and mES were checked. Also, in vitro differentiation potential of P-mES and mES was examined. RESULTS: Although the cleavage rate (> or =2-cell) was not different between IVF (76.3%) and parthenogenetic group (67.0%), in vitro development rate was significantly low in parthenogenetic group (24.0%) than IVF group (68.4%) (p<0.05). Cell number count of ICM and total cell in parthenogenetic blastocysts (9.6+/-3.1, 35.1+/-5.2) were significantly lower than those of IVF blastocysts (19.5+/-4.7, 63.2+/-13.0) (p<0.05). Through the serial treatment procedure such as immunosurgery, plating of ICM and colony formation, two ICM colonies in IVF group (mES, 10.0%) and three ICM colonies (P-mES, 42.9%) in parthenogenetic group were able to culture for extended duration (25 and 20 passages, respectively). Using surface markers, alkaline phosphatase, SSEA-1 and Oct4 in P-mES and mES colony were positively stained. The number of chromosome was normal in ES colony from two groups. Also, in vitro neural and cardiac differentiation derived from mES or P-mES cells was confirmed. CONCLUSION: This study suggested that P-mES cells can be successfully established and that those cell lines have similar characteristics to mES cells.
Alkaline Phosphatase
;
Animals
;
Antigens, CD15
;
Bisbenzimidazole
;
Blastocyst
;
Cell Count
;
Cell Line
;
Embryonic Stem Cells*
;
Embryonic Structures
;
Ethanol
;
Female
;
Fertilization in Vitro*
;
Humans
;
Male
;
Mice*
;
Oocytes
;
Propidium
7.A Novel Marker for Screening Paroxysmal Nocturnal Hemoglobinuria Using Routine Complete Blood Count and Cell Population Data.
Jimin KAHNG ; Yonggoo KIM ; Jung Ok KIM ; Kwangsang KOH ; Jong Wook LEE ; Kyungja HAN
Annals of Laboratory Medicine 2015;35(1):35-40
BACKGROUND: Final diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) may take years demanding a quick diagnosis measure. We used the facts that PNH cells are damaged in acid, and reagents for measuring reticulocytes in Coulter DxH800 (Beckman Coulter, USA) are weakly acidic and hypotonic, to create a new PNH screening marker. METHODS: We analyzed 979 complete blood counts (CBC) data from 963 patients including 57 data from 44 PNH patients. Standard criteria for PNH assay for population selection were followed: flow cytometry for CD55 and CD59 on red blood cells (RBCs) to a detection level of 1%; and fluorescent aerolysin, CD24 and CD15 in granulocytes to 0.1%. Twenty-four PNH minor clone-positive samples (minor-PNH+) were taken, in which the clone population was <5% of RBCs and/or granulocytes. Excluding PNH and minor-PNH+ patients, the population was divided into anemia, malignancy, infection, and normal groups. Parameters exhibiting a distinct demarcation between PNH and non-PNH groups were identified, and each parameter cutoff value was sought that includes the maximum [minimum] number of PNH [non-PNH] patients. RESULTS: Cutoff values for 5 selected CBC parameters (MRV, RDWR, MSCV, MN-AL2-NRET, and IRF) were determined. Positive rates were: PNH (86.0%), minor-PNH+ (33.3%), others (5.0%), anemia (13.4%), malignancy (5.3%), infection (3.7%), normal (0.0%); within anemia group, aplastic anemia (40.0%), immune hemolytic anemia (11.1%), iron deficiency anemia (1.6%). Sensitivity (86.0%), specificity (95.0%), PPV (52.1%), and NPV (99.1%) were achieved in PNH screening. CONCLUSION: A new PNH screening marker is proposed with 95% specificity and 86% sensitivity. The flag identifies PNH patients, reducing time to final diagnosis by flow cytometry.
Antigens, CD15/metabolism
;
Antigens, CD24/metabolism
;
Antigens, CD55/metabolism
;
Antigens, CD59/metabolism
;
Biomarkers/metabolism
;
Blood Cell Count
;
Erythrocytes/cytology/metabolism
;
Flow Cytometry
;
Granulocytes/cytology/metabolism
;
Hemoglobinuria, Paroxysmal/*diagnosis/metabolism
;
Humans
;
Sensitivity and Specificity
8.Establishment of Embryonic Stem Cell Line from Isolated Blastomeres from Mouse Preimplantation Embryos.
Chun Kyu LIM ; Ji Hye SUNG ; Hye Won CHOI ; Jae Won CHO ; Mi Ra SHIN ; Jin Hyun JUN
Korean Journal of Fertility and Sterility 2006;33(1):25-34
OBJECTIVE: The aim of this study was to investigate whether embryonic stem (ES) cells can be established from isolated blastomeres of mouse embryos. METHODS: Blastomeres were separated from mouse (C57Bl/6J) 2- or 4-cell embryos. Isolated blastomeres or whole 4-cell embryos were co-cultured with mitosis-arrested STO feeder cells in DMEM supplemented with recombinant murine leukemia inhibitory factor and ES-qualified fetal bovine serum. After the tentative ES cell lines were maintained from isolated blastomeres or whole embryos, some of them were frozen and the others were sub-cultured continually. Characteristics of tentative ES cell lines as were evaluated for specific gene expressions with immunocytochemistry and RT-PCR. RESULTS: One ES cell line (3.0%) was established from isolated blastomere of 2-cell embryo and one cell line (4.0%) from isolated two blastomeres of 4-cell embryo. And five cell lines (16.7%) were established from whole 4-cell embryos. Both cell lines from isolated blastomere and whole embryo expressed mouse ES cells specific markers such as SSEA-1, Oct-4 and alkaline phosphatase. Marker genes of three germ layers were expressed from embryoid bodies of both cell lines. CONCLUSION: This study suggests that mouse ES cells could be established from isolated blastomeres, although the efficiency is lower than whole embryos. This animal model could be applied to establishment of autologous human ES cells from biopsied blastomeres of preimplantation embryos in human IVF-ET program.
Alkaline Phosphatase
;
Animals
;
Antigens, CD15
;
Blastocyst*
;
Blastomeres*
;
Cell Line
;
Embryoid Bodies
;
Embryonic Stem Cells*
;
Embryonic Structures
;
Feeder Cells
;
Gene Expression
;
Germ Layers
;
Humans
;
Immunohistochemistry
;
Leukemia Inhibitory Factor
;
Mice*
;
Models, Animal